STRATTERA Side Effects

7023589-5 | Hyperhidrosis
on Sep 30, 2010 Male patient from UNITED STATES , 16 years of age, weighting 146.2 lb, was diagnosed with attention deficit/hyperactivity disorder, oppositional defiant disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis. Strattera dosage: 60mg Qd Po.

7020307-1 | Hypotension, Syncope
Patient was taking Strattera (View Usage). Patient had the following side effects: hypotension, syncope on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 15 years of age, . Strattera dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

7020291-0 | Acne, Completed Suicide
Adverse event was reported on Sep 16, 2010 by a Female patient taking Strattera (View Usage) (Dosage: ) . Location: UNITED STATES , 16 years of age, After Strattera was administered, patient had the following side effects: acne (What is acne?), completed suicide.

7017947-2 | Chemical Injury, Dyspnoea, Stridor
on Sep 15, 2010 Male patient from UNITED STATES , child 9 years of age, was diagnosed with psychomotor hyperactivity and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: chemical injury, dyspnoea, stridor. Strattera dosage: . Patient was hospitalized.


7009305-1 | Suicide Attempt
on Sep 10, 2010 Female patient from UNITED STATES , 14 years of age, weighting 114.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: suicide attempt. Strattera dosage: . During the same period patient was treated with ANTIPSYCHOTICS (View Antipsychotics Review and Antipsychotics Label ).

7003305-3 | Completed Suicide
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: completed suicide on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 35 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: . During the same period patient was treated with EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ).

6994291-0 | Vascular Purpura
Adverse event was reported on Sep 06, 2010 by a Male patient taking Strattera (View Usage) (Dosage: Unk, Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: JAPAN , child 8 years of age, Patient experienced the following unwanted or unexpected effects: vascular purpura. Patient was hospitalized.

6984900-4 | Brain Neoplasm, Convulsion
on Sep 02, 2010 Male patient from AUSTRALIA , weighting 47.18 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: brain neoplasm, convulsion. Strattera dosage: .

6984888-6 | Agitation, Paranoia, Restlessness, Suicidal Ideation
on Sep 02, 2010 Male patient from AUSTRALIA , weighting 183.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: agitation, paranoia, restlessness, suicidal ideation. Strattera dosage: 100 Meq, Daily (1/d).

6979653-X | Anger, Erection Increased, Insomnia, Irritability, Somnolence
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: anger, erection increased, insomnia, irritability, somnolence on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 120.0 lb, . Strattera dosage: 40 Mg 1xdaily.

6978310-3 | Pituitary Tumour Benign
Adverse event was reported on Aug 31, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 25 Mg, Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 20 years of age, Patient had the following side effects: pituitary tumour benign. During the same period patient was treated with ZOLOFT (50 Mg, Unk) (View Zoloft Review and Zoloft Label ).

6972980-1 | Urethral Stenosis
on Aug 27, 2010 Male patient from JAPAN , child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: urethral stenosis. Strattera dosage: 40 Mg, Daily (1/d). During the same period patient was treated with DEPROMEL /00615201/ (View Depromel /00615201/ Review and Depromel /00615201/ Label ).

6969264-4 | Peripheral Nerve Injury, Peripheral Vascular Disorder
on Aug 25, 2010 Male patient from GERMANY , weighting 227.1 lb, was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: peripheral nerve injury, peripheral vascular disorder. Strattera dosage: . Patient was hospitalized.

6962404-2 | Haemoglobin Decreased, Hepatitis Acute, International Normalised Ratio Increased, Platelet Count Decreased, Prothrombin Time Prolonged, White Blood Cell Count Decreased
Patient was taking Strattera (View Usage). Patient had the following side effects: haemoglobin decreased, hepatitis acute, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, white blood cell count decreased on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , 20 years of age, weighting 113.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: Unk, Unk. Patient was hospitalized.

6962312-7 | Anti Factor Viii Antibody Test, Haemarthrosis, Oedema
Adverse event was reported on Aug 23, 2010 by a Male patient taking Strattera (View Usage) (Dosage: Unk Unk, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: GREECE , child 8 years of age, After Strattera was administered, patient had the following side effects: anti factor viii antibody test, haemarthrosis, oedema. During the same period patient was treated with HYPNOTICS AND SEDATIVES (View Hypnotics And Sedatives Review and Hypnotics And Sedatives Label ). Patient was hospitalized.

6962310-3 | White Blood Cell Count Decreased
on Aug 22, 2010 Male patient from UNITED STATES , child 6 years of age, weighting 44.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased. Strattera dosage: 10 Mg, Unk. During the same period patient was treated with METHYLPHENIDATE SLOW RELEASE (10 Mg, Daily (1/d)) (View Methylphenidate - Slow Release Review and Methylphenidate - Slow Release Label ), METHYLPHENIDATE SLOW RELEASE (36 Mg, Daily (1/d)) (View Methylphenidate - Slow Release Review and Methylphenidate - Slow Release Label ), IMIPRAMINE HYDROCHLORIDE (25 Mg, Daily (1/d)) (View Imipramine Hydrochloride Review and Imipramine Hydrochloride Label ), ARIPIPRAZOLE (2.5 Mg, Daily (1/d)) (View Aripiprazole Review and Aripiprazole Label ), CLONIDINE (0.05 Mg, Daily (1/d)) (View Clonidine Review and Clonidine Label ).

6957640-5 | Anxiety, Crying, Depressed Mood, Homicidal Ideation, Suicidal Ideation
on Aug 18, 2010 Female patient from CANADA , 14 years of age, was treated with Strattera (View Usage). Patient had the following side effects: anxiety (What is anxiety?), crying, depressed mood, homicidal ideation, suicidal ideation. Strattera dosage: 60 Mg, Unk.

6955229-5 | Adverse Event, Agitation, Dysphagia, Homicidal Ideation, Off Label Use, Vomiting Projectile
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: adverse event, agitation, dysphagia, homicidal ideation, off label use, vomiting projectile on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Strattera dosage: .

6942849-7 | Aggression, Irritability, Personality Change, Vomiting
Adverse event was reported on Aug 12, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: SPAIN , child 7 years of age, Patient experienced the following unwanted or unexpected effects: aggression, irritability, personality change, vomiting.

6938496-3 | Fall, Movement Disorder, Nausea
on Aug 10, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: fall (What is fall?), movement disorder (What is movement disorder?), nausea (What is nausea?). Strattera dosage: 1 D/f, Unk. During the same period patient was treated with BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), SOMA (View Soma Review and Soma Label ). Patient was hospitalized.

6938493-8 | Feeling Jittery, Muscle Contractions Involuntary
on Aug 10, 2010 Female patient from SOUTH AFRICA , child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: feeling jittery, muscle contractions involuntary. Strattera dosage: . Patient was hospitalized.

6938491-4 | Hospitalisation
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: hospitalisation on Aug 10, 2010 from UNITED STATES Additional patient health information: Male patient , 26 years of age, . Strattera dosage: . Patient was hospitalized.

6937645-0 | Epistaxis, Mood Swings
Adverse event was reported on Aug 20, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 60mg 1x Daily Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 16 years of age, weighting 145.3 lb, Patient had the following side effects: epistaxis, mood swings.

6935810-X | Extrapyramidal Disorder
on Aug 09, 2010 Male patient from COLOMBIA , child 9 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: extrapyramidal disorder. Strattera dosage: 18 Mg, Unk.

6933012-4 | Chills, Decreased Appetite, Fatigue, Heart Rate Increased, Hyperhidrosis, Nausea, Piloerection
on Aug 18, 2010 Female patient from UNITED STATES , weighting 133.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: chills, decreased appetite, fatigue, heart rate increased, hyperhidrosis, nausea (What is nausea?), piloerection. Strattera dosage: 60 Mg 1x/day Oral.

6932505-3 | Asthma
Patient was taking Strattera (View Usage). Patient had the following side effects: asthma (What is asthma?) on Aug 06, 2010 from UNITED STATES Additional patient health information: Male patient , 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 10 Mg, Daily (1/d). During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6923785-9 | Hyperammonaemia
Adverse event was reported on Aug 03, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 18 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 6 years of age, After Strattera was administered, patient had the following side effects: hyperammonaemia. During the same period patient was treated with CONCERTA (54 Mg, Unk) (View Concerta Review and Concerta Label ), CLONIDINE (0.05 Mg, Daily (1/d)) (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6921345-7 | Aggression, Confusional State, Depressed Level Of Consciousness, Hypoglycaemia, Muscle Twitching, Mydriasis, Myoclonus
on Jul 29, 2010 Male patient from SWEDEN , 39 years of age, was diagnosed with attention deficit/hyperactivity disorder, neuralgia, pain (What is pain?) and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, confusional state, depressed level of consciousness, hypoglycaemia, muscle twitching, mydriasis, myoclonus. Strattera dosage: 80 Mg, Daily (1/d). During the same period patient was treated with GABAPENTIN ACTAVIS (300 Mg, Daily (1/d)) (View Gabapentin Actavis Review and Gabapentin Actavis Label ), TRAMADOL HYDROCHLORIDE (400 Mg, Daily (1/d)) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), KLOMIPRAMIN MYLAN (100 Mg, Daily (1/d)) (View Klomipramin Mylan Review and Klomipramin Mylan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), OMEPRAZOL ABCUR (View Omeprazol Abcur Review and Omeprazol Abcur Label ), LEVEMIR (View Levemir Review and Levemir Label ), NULYTELY (View Nulytely Review and Nulytely Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6919014-2 | Gastrostomy Tube Insertion, Hospitalisation
on Jul 28, 2010 Female patient from UNITED STATES , 65 years of age, was treated with Strattera (View Usage). Patient had the following side effects: gastrostomy tube insertion, hospitalisation. Strattera dosage: 100 Mg, Daily (1/d). Patient was hospitalized.

6919013-0 | Gastroenteritis, Subcutaneous Abscess, Superinfection
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?), subcutaneous abscess, superinfection on Jul 28, 2010 from BELGIUM Additional patient health information: Male patient , weighting 66.14 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: .

6919011-7 | Self Injurious Behaviour, Suicidal Behaviour
Adverse event was reported on Jul 28, 2010 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , child 9 years of age, Patient experienced the following unwanted or unexpected effects: self injurious behaviour, suicidal behaviour. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ).

6918997-4 | Fatigue, Presyncope
on Jul 28, 2010 Female patient from UNITED STATES , 15 years of age, weighting 143.0 lb, was treated with Strattera (View Usage). Patient had the following side effects: fatigue, presyncope. Strattera dosage: 80 Mg, Unk.

6917294-0 | Pancreatitis
on Jul 27, 2010 Male patient from AUSTRALIA , child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: pancreatitis. Strattera dosage: 18 Mg, Daily (1/d). Patient was hospitalized.

6908418-X | Ascites, Asterixis, Blood Bilirubin Increased, Confusional State, Contusion, Jaundice, Palmar Erythema
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, asterixis, blood bilirubin increased, confusional state, contusion, jaundice (What is jaundice?), palmar erythema on Jul 23, 2010 from GERMANY Additional patient health information: Male patient , child 12 years of age, weighting 63.93 lb, . Strattera dosage: 35 Mg, Daily (1/d). During the same period patient was treated with METHYLPHENIDAT (View Methylphenidat Review and Methylphenidat Label ), RISPERIDON (View Risperidon Review and Risperidon Label ), ROXITHROMYCIN (View Roxithromycin Review and Roxithromycin Label ).

6905862-1 | Paranoia, Suicidal Ideation
Adverse event was reported on Jul 22, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 100 Meq, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: AUSTRALIA , 17 years of age, Patient had the following side effects: paranoia, suicidal ideation.

6900196-3 | Hepatitis Acute, Platelet Count Decreased, Prothrombin Time Prolonged, White Blood Cell Count Decreased
on Jul 21, 2010 Female patient from UNITED STATES , 20 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: hepatitis acute, platelet count decreased, prothrombin time prolonged, white blood cell count decreased. Strattera dosage: . Patient was hospitalized.

6900183-5 | Anti Factor Viii Antibody Test, Haemarthrosis
on Jul 20, 2010 Male patient from GREECE , child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: anti factor viii antibody test, haemarthrosis. Strattera dosage: Unk Unk, Daily (1/d). Patient was hospitalized.

6900182-3 | Cardiomyopathy, Ejection Fraction Decreased
Patient was taking Strattera (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), ejection fraction decreased on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 18 Mg, Unk.

6895037-7 | Self-injurious Ideation, Suicidal Ideation
Adverse event was reported on Jul 19, 2010 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 6 years of age, weighting 58.99 lb, After Strattera was administered, patient had the following side effects: self-injurious ideation, suicidal ideation. During the same period patient was treated with ADDERALL XR 10 (View Adderall Xr 10 Review and Adderall Xr 10 Label ).

6882059-5 | Acne, Agitation, Anxiety, Arrhythmia, Chest Pain, Disturbance In Attention, Dizziness, Impulsive Behaviour, Insomnia
on Jul 15, 2010 Male patient from SPAIN , weighting 94.80 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), agitation, anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), chest pain (What is chest pain?), disturbance in attention, dizziness (What is dizziness?), impulsive behaviour, insomnia. Strattera dosage: 25 Mg, Daily (1/d). Patient was hospitalized.

6882051-0 | Abdominal Pain, Constipation, Decreased Appetite, Nausea, Rectal Haemorrhage, Weight Decreased
on Jul 16, 2010 Female patient from CANADA , 14 years of age, was treated with Strattera (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), decreased appetite, nausea (What is nausea?), rectal haemorrhage, weight decreased. Strattera dosage: 25 Mg, Unk. Patient was hospitalized.

6878022-0 | Hepatitis, Hepatomegaly, Pancreatitis
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: hepatitis (What is hepatitis?), hepatomegaly, pancreatitis on Jul 12, 2010 from GERMANY Additional patient health information: Male patient , 15 years of age, weighting 119.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: . Patient was hospitalized.

6876661-4 | Hepatitis, Hepatomegaly, Pancreatitis
Adverse event was reported on Jul 12, 2010 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: GERMANY , 15 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), hepatomegaly, pancreatitis. Patient was hospitalized.

6876538-4 | Completed Suicide
on Jul 13, 2010 Male patient from UNITED STATES , 35 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: completed suicide. Strattera dosage: . During the same period patient was treated with EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ).

6876491-3 | Jaundice
on Jul 13, 2010 Male patient from IRELAND , weighting 68.34 lb, was diagnosed with attention deficit/hyperactivity disorder, asthma (What is asthma?) and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: jaundice (What is jaundice?). Strattera dosage: 18 Mg, Daily (1/d). During the same period patient was treated with ALBUTEROL (Unk, As Needed) (View Albuterol Review and Albuterol Label ).

6876490-1 | Dermatitis Exfoliative, Hepatitis
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, hepatitis (What is hepatitis?) on Jul 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 162.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60 Mg, Unk. During the same period patient was treated with CELEBREX (200 Mg, Daily (1/d)) (View Celebrex Review and Celebrex Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6870827-5 | Acute Myocardial Infarction
Adverse event was reported on Jul 12, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 25 Mg, Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 20 years of age, Patient had the following side effects: acute myocardial infarction. Patient was hospitalized.

6860396-8 | Extrapyramidal Disorder, Eye Movement Disorder, Salivary Hypersecretion
on Jul 07, 2010 Male patient from COLOMBIA , child 9 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: extrapyramidal disorder, eye movement disorder, salivary hypersecretion. Strattera dosage: 18 Mg, Unk.

6849569-8 | Hyperammonaemia
on Jul 06, 2010 Male patient from UNITED STATES , child 6 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: hyperammonaemia. Strattera dosage: 18 Mg, Daily (1/d). During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6849393-6 | Aggression, Crying, Homicidal Ideation, Irritability
Patient was taking Strattera (View Usage). Patient had the following side effects: aggression, crying, homicidal ideation, irritability on Jul 06, 2010 from DENMARK Additional patient health information: Male patient , weighting 55.12 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 18 Mg, Daily (1/d). During the same period patient was treated with MEDIKINET (20 Mg, 2/d) (View Medikinet Review and Medikinet Label ).